127 related articles for article (PubMed ID: 36741265)
41. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
42. ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice.
Kimura Y; Fukuda A; Ogawa S; Maruno T; Takada Y; Tsuda M; Hiramatsu Y; Araki O; Nagao M; Yoshikawa T; Ikuta K; Yoshioka T; Wang Z; Akiyama H; Wright CV; Takaori K; Uemoto S; Chiba T; Seno H
Gastroenterology; 2018 Jul; 155(1):194-209.e2. PubMed ID: 29604291
[TBL] [Abstract][Full Text] [Related]
43. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
44. The testis-specifically expressed gene
He X; Xie W; Li H; Cui Y; Wang Y; Guo X; Sha J
J Biomed Res; 2020 Aug; 35(1):47-60. PubMed ID: 33273151
[TBL] [Abstract][Full Text] [Related]
45. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
46. Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Arundhathi A; Chuang WH; Chen JK; Wang SE; Shyr YM; Chen JY; Liao WN; Chen HW; Teng YM; Pai CC; Wang CH
Oncotarget; 2016 Aug; 7(34):55437-55448. PubMed ID: 28874965
[TBL] [Abstract][Full Text] [Related]
47. EYA4 Promotes Cell Proliferation Through Downregulation of p27Kip1 in Glioma.
Li Z; Qiu R; Qiu X; Tian T
Cell Physiol Biochem; 2018; 49(5):1856-1869. PubMed ID: 30231237
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
49. A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy.
Arbel Rubinstein T; Reuveni I; Hesin A; Klein-Goldberg A; Olauson H; Larsson TE; Abraham CR; Zeldich E; Bosch A; Chillón M; Hollander KS; Shabtay-Orbach A; Vainer GW; Wolf I; Rubinek T
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944918
[TBL] [Abstract][Full Text] [Related]
50. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
51. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
[TBL] [Abstract][Full Text] [Related]
52. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.
Li C; Dong Q; Che X; Xu L; Li Z; Fan Y; Hou K; Wang S; Qu J; Xu L; Wen T; Yang X; Qu X; Liu Y
BMC Cancer; 2018 Jun; 18(1):681. PubMed ID: 29940895
[TBL] [Abstract][Full Text] [Related]
54. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
[TBL] [Abstract][Full Text] [Related]
55. Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.
Kalbasi A; Komar C; Tooker GM; Liu M; Lee JW; Gladney WL; Ben-Josef E; Beatty GL
Clin Cancer Res; 2017 Jan; 23(1):137-148. PubMed ID: 27354473
[TBL] [Abstract][Full Text] [Related]
56. TRIM69 inhibits cataractogenesis by negatively regulating p53.
Rong X; Rao J; Li D; Jing Q; Lu Y; Ji Y
Redox Biol; 2019 Apr; 22():101157. PubMed ID: 30844644
[TBL] [Abstract][Full Text] [Related]
57. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
58. Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization.
Li JT; Li KY; Su Y; Shen Y; Lei MZ; Zhang F; Yin M; Chen ZJ; Wen WY; Hu WG; Su D; Qu J; Lei QY
Natl Sci Rev; 2022 May; 9(5):nwab212. PubMed ID: 35663242
[TBL] [Abstract][Full Text] [Related]
59. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
Morton JP; Timpson P; Karim SA; Ridgway RA; Athineos D; Doyle B; Jamieson NB; Oien KA; Lowy AM; Brunton VG; Frame MC; Evans TR; Sansom OJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):246-51. PubMed ID: 20018721
[TBL] [Abstract][Full Text] [Related]
60. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]